One of the most likely vaccine candidates for the corona virus vaccine, the US pharmaceutical company Pfizer Inc, has a big claim on the vaccine. The company said that the Phase III study of our Covid-19 vaccine has met all the key points. The study reached 170 confirmed cases of Kovid-19. The vaccine candidate BNT163B2 (BNT162b2) showed a 95% effective onset 28 days after the first dose.
Pfizer’s Phase III Study Demostrate 95% Efficacy
Date:
More like thisRelated
A Decade of Agricultural Legislation Under the BJP Regime: The Bleak Truth
Table of Contents1. Overview of Key Agricultural Bills1.1 The...
PUBLIC DISTRIBUTION SYSTEM AND CONGRESS’ ROLE IN ITS EVOLUTION A BRIEF INTRODUCTION:
The Public Distribution System (PDS) in India is indeed...